Cite
HARVARD Citation
Gómez‐Bañuelos, E. et al. (2022). Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis. Arthritis & rheumatology. 74 (11), pp. 1746-1754. [Online].